Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC12334 | PF-05241328 |
PF-05241328 is a potent and selective inhibitor of human Nav1.7 voltage-dependent sodium channels (Nav1.7), with an IC50 of 31 nM.
More description
|
![]() |
DC22221 | PF-05212377 |
PF-05212377 (SAM-760, PF 5212377) is a potent and selective 5-HT6 receptor antagonist with potential therapy for the symptomatic treatment of mild to moderate Alzheimer's disease..
More description
|
![]() |
DC23667 | PF-04991532 |
PF-04991532 (PF4991532) is a potent, hepatoselective Glucokinase (GK) activator with EC50 of 90±45 nM.
More description
|
![]() |
DC8527 | PF-04979064 |
PF-04979064 is a highly potent and orally bioavailable PI3K/mTOR dual inhibitor developed through structure-based drug design. It inhibited mTOR, PI3Kα, β, δ and γ isoforms and AKT phosphorylation with IC50 as 2.64 nM, 0.395 nM, 0.111 nM, 0.122 nM and 28.
More description
|
![]() |
DC23629 | PF-04958242 |
PF-04958242 is a novel potent, selctive, and orally-active AMPA receptor (AMPAR) positive allosteric modulator (PAM) with Ki of 170 nM, EC50 of 370 nM.
More description
|
![]() |
DC10418 | PF-04957325 |
PF-04957325 is a highly potent and selective PDE8 inhibitor, with IC50 values of 0.7 nM for PDE8A and less than 0.3 nM for PDE8B.
More description
|
![]() |
DC22113 | PF-04895162 |
PF-04895162 (ICA-105665, PF 4895162) is an orally available agonist of neuronal Kv7 potassium channel, opens Kv7.2/7.3 and Kv7.3/7.5 potassium channels, also known as KCNQ2/3 and KCNQ3/5 channels.
More description
|
![]() |
DC23631 | PF-04701475 |
PF-04701475 is a nove positive allosteric modulator of AMPA receptor, a prototype used to explore AMPAR-mediated pharmacology in vivo..
More description
|
![]() |
DC23682 | PF-04677490 |
PF-04677490 is a potent, selective PDE1 inhibitor with IC50 of 21 nM for PDE1B.
More description
|
![]() |
DC22409 | PF-04634817 succinate |
PF-04634817 is a potent, orally bioavailble CCR2 and CCR5 chemokine receptor antagonist, for the treatment of diabetic nephropathies and diabetic macular oedema. .
More description
|
![]() |
DC22408 | PF-04634817 |
PF-04634817 is a potent, orally bioavailble CCR2 and CCR5 chemokine receptor antagonist for the treatment of diabetic nephropathies and diabetic macular oedema. .
More description
|
![]() |
DC21499 | PF-04531083 |
PF-04531083 (PF 4531083) is a potent and selective, orally available sodium channel Nav1.8 blocker for treatment of pain. .
More description
|
![]() |
DC12550 | PF-04449613 |
PF-04449613 (PF04449613) is a potent and selective inhibitor of PDE9..
More description
|
![]() |
DC21479 | PF-04308515 |
PF-04308515 (PF 4308515) is a potent glucocorticoid receptor (GR) agonist with anti-inflammatory activity..
More description
|
![]() |
DC21498 | PF-04191834 |
PF-04191834 (PF-4191834) is a potent, non‐iron chelating, non‐redox, selective and competitive inhibitor of 5-lipoxygenase (5‐LO) with Ki of 10 nM.
More description
|
![]() |
DC23708 | PF-03882845 |
PF-03882845 is highly potent, selective, nonsteroidal, orally bioavailable Mineralocorticoid receptor antagonist with IC50 of 4.5 nM.
More description
|
![]() |
DC9367 | PF-03814735 |
PF-03814735 is a novel, potent, orally bioavailable, reversible small-molecule Aurora kinase inhibitor with IC50 of 0.8, 5, 10 and 22 nM for Aurora A, Aurora B, Flt 1 and FAk, respectively.
More description
|
![]() |
DC23448 | PF-03654764 |
PF-03654764 (PF 3654764) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 1.4 nM.
More description
|
![]() |
DC23422 | PF-03654746 |
PF-03654746 (PF 3654746) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 2.3 nM.
More description
|
![]() |
DC23622 | PF-03463275 |
PF-03463275 (PF 3463275) ia an orally bioavailable, centrally penetrant, potent, reversible, selective, and competitive inhibitor of the human GlyT1 transporter with Ki of 13 nM.
More description
|
![]() |
DC21496 | PF-03382792 |
PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication..
More description
|
![]() |
DC21470 | PF-03049423 |
PF-03049423 is a potent, selective, orally active, and brain penetrant inhibitor of PDE5 with IC50 of 0.2 nM.
More description
|
![]() |
DC23574 | PF-02575799 |
PF-02575799 is a highly potent microsomal triglyceride transfer protein (MTP) inhibitor with IC50 of 0.77 nM.
More description
|
![]() |
DC21495 | PF-02413873 |
PF-02413873 (PF-2413873) is a potent, selective, fully competitive, and orally active progesterone receptor (PR) antagonist with Ki of 9.7 nM.
More description
|
![]() |
DC21500 | PF-00610355 |
PF-00610355 (PF 610355) is a potent, selective, and long-acting β2-adrenoreceptor agonist with EC50 of 0.26 nM.
More description
|
![]() |
DC11665 | PF-00446687 |
PF-00446687(PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM.
More description
|
![]() |
DC11664 | PF-00446687 hydrochloride |
PF-00446687 hydrochloride (PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM.
More description
|
![]() |
DC21516 | PF 5212372 |
PF 5212372 (PLA-950, ZPL-521, ZPL 5212372) is a potent, selective inhibitor of cPLA2 (cytosolic phospholipase A2α) with IC50 of 7 nM.
More description
|
![]() |
DC8147 | PF 4800567 |
PF 4800567 is a selective casein kinase 1ε inhibitor; displays 22-fold greater potency towards CK1ε than CK1δ (IC50 values are 32 and 711 nM for CK1ε and CK1δ respectively).
More description
|
![]() |
DC10356 | PF 03716556 |
PF 03716556 is a potent, and selective acid pump (H+,K+ ATPase) antagonist, with pIC50 value of 6.009.
More description
|
![]() |